The Institute for Clinical and Economic Review (ICER) has appointed new members to each of its three independent evidence appraisal councils: the California Technology Assessment Forum (CTAF), the Midwest Comparative Effectiveness Public Advisory Council (Midwest CEPAC), and the New England Comparative Effectiveness Public Advisory Council (New England CEPAC).
“Our evidence appraisal councils play a vital role in ICER’s work, representing an open, transparent forum to receive input from patients, clinical experts, and other stakeholders, and then to deliberate and vote on the evidence regarding the comparative clinical effectiveness and value of health interventions,” ICER President Steven Pearson said. “The discussions during each of ICER’s public meetings reflect the dedication and rigor of each member of these councils, and we look forward to the perspectives that this year’s distinguished new members will add.”
The new members join the councils of regionally-based experts who represent a broad range of perspectives including medical ethics, patient advocacy and engagement, outcomes research, health economics, technology assessment, and clinical practice.
To find out who was appointed to each council, click here.